Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
0.688
-0.005 (-0.71%)
At close: Dec 5, 2025, 4:00 PM EST
0.694
+0.006 (0.92%)
After-hours: Dec 5, 2025, 4:00 PM EST
Elutia Revenue
Elutia had revenue of $3.32M in the quarter ending September 30, 2025, a decrease of -9.26%. This brings the company's revenue in the last twelve months to $21.75M, up 24.08% year-over-year. In the year 2024, Elutia had annual revenue of $24.38M, down -1.50%.
Revenue (ttm)
$21.75M
Revenue Growth
+24.08%
P/S Ratio
1.26
Revenue / Employee
$426,392
Employees
51
Market Cap
29.36M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ELUT News
- 4 weeks ago - Elutia Inc. (ELUT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development - GlobeNewsWire
- 6 weeks ago - Elutia to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 - GlobeNewsWire
- 7 weeks ago - Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21 - GlobeNewsWire
- 2 months ago - Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors - GlobeNewsWire
- 2 months ago - Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million - GlobeNewsWire
- 2 months ago - Elutia Announces Newly Published Clinical Data Demonstrating that Biologic Envelopes Support CIED Stabilization and Ease of Reoperation - GlobeNewsWire
- 3 months ago - Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million - GlobeNewsWire